Evidence map›Paper›PMID 20454613›Full record

ArticlePloS one2010

In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Irina V Lyadova, Evgeny N Tsiganov, Marina A Kapina, Galena S Shepelkova, Vasily V Sosunov, Tatiana V Radaeva, Konstantin B Majorov, Natalya S Shmitova, Henk-Jan van den Ham, Vitaly V Ganusov and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Emerging patterns of regulatory T cell function in tuberculosis.Clinical and experimental immunology · 2020
    Review
  13. Article
  14. Article
  15. Frontiers in immunology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Irina V LyadovaDepartment of Immunology, Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation. ivlyadova@mail.ru
Evgeny N Tsiganov
Marina A Kapina
Galena S Shepelkova
Vasily V Sosunov
Tatiana V Radaeva
Konstantin B Majorov
Natalya S Shmitova
Henk-Jan van den Ham
Vitaly V Ganusov
Rob J De Boer
Rachael Racine
Gary M Winslow
Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RUUtrecht University · NLInstitute of Biophysics · RUNew York State Department of Health · USWadsworth Center · US

Funding

Cellular and molecular pathways of tuberculosis progressionR01AI078899 · NIAID · CENTRAL INSTITUTE FOR TUBERCULOSIS · PI LYADOVA, IRINA V · 2009 to 2012
$427k
NIAID NIH HHS 1R01AI078899NIAID NIH HHS R01 AI078899
6 · The paper itself

Abstract

backgroundInfection with Mycobacterium tuberculosis (Mtb) results in different clinical outcomes ranging from asymptomatic containment to rapidly progressing tuberculosis (TB). The mechanisms controlling TB progression in immunologically-competent hosts remain unclear. METHODOLOGY/PRINCIPAL

findingsTo address these mechanisms, we analyzed TB progression in a panel of genetically heterogeneous (A/SnxI/St) F2 mice, originating from TB-highly-susceptible I/St and more resistant A/Sn mice. In F2 mice the rates of TB progression differed. In mice that did not reach terminal stage of infection, TB progression did not correlate with lung Mtb loads. Nor was TB progression correlated with lung expression of factors involved in antibacterial immunity, such as iNOS, IFN-gamma, or IL-12p40. The major characteristics of progressing TB was high lung expression of the inflammation-related factors IL-1beta, IL-6, IL-11 (p<0.0003); CCL3, CCL4, CXCL2 (p<0.002); MMP-8 (p<0.0001). The major predictors of TB progression were high expressions of IL-1beta and IL-11. TNF-alpha had both protective and harmful effects. Factors associated with TB progression were expressed mainly by macrophages (F4-80(+) cells) and granulocytes (Gr-1(hi)/Ly-6G(hi) cells). Macrophages and granulocytes from I/St and A/Sn parental strains exhibited intrinsic differences in the expression of inflammatory factors, suggesting that genetically determined peculiarities of phagocytes transcriptional response could account for the peculiarities of gene expression in the infected lungs. Another characteristic feature of progressing TB was the accumulation in the infected lungs of Gr-1(dim) cells that could contribute to TB progression. CONCLUSIONS/SIGNIFICANCE: In a population of immunocompetent hosts, the outcome of TB depends on quantitatively- and genetically-controlled differences in the intensity of inflammatory responses, rather than being a direct consequence of mycobacterial colonization. Local accumulation of Gr-1(dim) cells is a newly identified feature of progressing TB. High expression of IL-1beta and IL-11 are potential risk factors for TB progression and possible targets for TB immunomodulation.

Indexed as

AnimalsAntigens, LyColony Count, MicrobialCrosses, GeneticDisease ProgressionDisease SusceptibilityFemaleGranulocytesInflammation MediatorsLungMaleMiceMycobacterium tuberculosisPhagocytesPneumoniaQuantitative Trait LociAntigens, LyInflammation MediatorsLy6G antigen, mouse

Identifiers

PMID20454613
PMCPMC2864263
OpenAlexW2077157529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.